Table 3b.
Frontal lobe plasmalogen mass in SSADH deficient patient and control group
| nmol/g ww | mol % | |||||
|---|---|---|---|---|---|---|
|
|
||||||
| Patient | Mean (control) | SD | Patient | Mean (control) | SD | |
|
|
||||||
| EtnGpl | 7027 | 6512 | 1295 | 56.1% | 40.6% | 5.8%* |
| PlsEtn | 5492 | 9641 | 2191 | 43.9% | 59.4% | 5.8%* |
| ChoGpl | 12924 | 12912 | 2236 | 90.1% | 89.1% | 1.1% |
| PlsCho | 1415 | 1562 | 147 | 9.9% | 10.9% | 1.1% |
| n = 1 | n = 4 | |||||
Mass values are expressed as nmol phosphorus/gram wet weight tissue and represent mean±SD of control and patient values. Molar composition values are expressed as mol % of total phosphorus. n = 2–4.
*
indicates significance between patient and control group, 2 SD from control mean.